We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current SVA market cap is 460.27M. The company's latest EPS is USD -3.6317 and P/E is -1.78.
| Quarter End | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 81.11M | 15.39M | 52.33M | 115.45M | 327.45M |
| Operating Income | 28.79M | -8.63M | 660k | 28.19M | 198.06M |
| Net Income | 21.68M | -7.36M | -5.26M | 9.65M | 107.32M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 246.05M | 510.62M | 19.37B | 1.49B | 448.27M |
| Operating Income | 69.46M | 218.28M | 17.56B | -456.59M | -521.66M |
| Net Income | 39.8M | 104.35M | 8.46B | 88.13M | -258.36M |
| Quarter End | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 452.3M | 433.32M | 529.37M | 658.56M | 1.9B |
| Total Liabilities | 100.1M | 93.83M | 191.38M | 281.31M | 781.2M |
| Total Equity | 352.2M | 339.5M | 337.99M | 377.25M | 1.12B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 452.3M | 1.9B | 16.75B | 14.11B | 13.66B |
| Total Liabilities | 100.1M | 781.2M | 2.87B | 1.4B | 1.64B |
| Total Equity | 352.2M | 1.12B | 13.88B | 12.71B | 12.02B |
| Quarter End | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 39.07M | -18.24M | -15.89M | -1.79M | 479.31M |
| Investing | -42.45M | 25.65M | -22.22M | -52.61M | -204.76M |
| Financing | 1.74M | 6.65M | 27.87M | 50.92M | 592.57M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 39.07M | 479.31M | 15.35B | -770.75M | 104M |
| Investing | -42.45M | -204.76M | -3.02B | -5.76B | -2.92B |
| Financing | 1.74M | 592.57M | -1.9B | -241.4M | -76.06M |
| Market Cap | 460.27M |
| Price to Earnings Ratio | -1.78 |
| Price to Sales Ratio | 1.03 |
| Price to Cash Ratio | 0.36 |
| Price to Book Ratio | 0.04 |
| Dividend Yield | - |
| Shares Outstanding | 71.14M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | 0.00% |
| 52 Week High | 6.47 |
| 52 Week Low | 6.47 |
| Spread (Intraday) | -0.21 (-3.35%) |
| Company Name | Sinovac Biotech Ltd |
| Address |
36 long street saint john |
| Website | https://www.sinovac.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
